Pesticide Registration Mosquito Repellent Efficacy Testing: Complete Protection Time Evaluation and

Pesticide registration mosquito repellent testing is the mandatory efficacy evaluation that topical and spatial repellent products must undergo before they can be legally registered and marketed as public health pesticides. This testing, performed by accredited third-party laboratories in accordance with national standards such as the GB/T 13917 series and WHO guidelines, measures key performance indicators including complete protection time (CPT) and protection rate. This article explains the regulatory background, sample types, test items, laboratory and field methodologies, and evaluation criteria involved in mosquito repellent efficacy testing for pesticide registration.

Technical Overview

In most major markets, mosquito repellents are legally classified as pesticides or biocides because they contain active substances intended to repel disease-vector or nuisance insects. Under the pesticide regulatory framework administered by national registration authorities, any product claiming to repel mosquitoes—whether applied to human skin or released into living spaces—must be supported by validated efficacy data before registration approval. This data package is generated through standardized laboratory and field studies conducted by accredited third-party laboratories.

The core performance endpoint for skin-applied repellents is complete protection time (CPT), defined as the elapsed time between product application and the first confirmed mosquito landing or probing event on the treated skin. For vaporizing or spatial repellent products, knockdown rate, mortality, and protection rate serve as the primary indicators. In China, the governing methodology is the GB/T 13917 series of national standards, particularly the part covering repellents (GB/T 13917.9), which specifies the arm-in-cage test design, mosquito species, environmental conditions, and grading criteria. These methods align closely with WHO guidelines for efficacy testing of topical repellents and with internationally recognized product performance test guidelines.

Regulators use these results to verify that labeled claims—such as "up to 6 hours of protection"—are scientifically substantiated, that the product delivers consistent performance across batches, and that the active ingredient concentration is appropriate for consumer use.

Testing Samples

Topical Skin Repellents

This category includes pump sprays, aerosol sprays, lotions, creams, roll-ons, gels, and wipes formulated with established active ingredients such as DEET, icaridin (picaridin), IR3535, p-menthane-3,8-diol (PMD), or plant-derived oils such as citronella and oil of lemon eucalyptus. These products are evaluated directly on human volunteers using the arm-in-cage method.

Repellent-Treated Wearables and Articles

Repellent-impregnated wristbands, stickers, patches, clothing, and textiles are tested to determine the zone of protection around the article and the duration of effectiveness, as well as residual efficacy after simulated use conditions such as washing or sweating.

Spatial and Vapor-Acting Products

Electric vaporizer liquids, vaporizing mats, coils, and passive emanator devices that release repellent or insecticidal vapor into the air are evaluated in sealed test chambers for vapor-phase activity, knockdown, and protection performance under room-scale conditions.

Formulations and Technical-Grade Active Ingredients

Registration dossiers may also require supporting tests on the technical-grade active ingredient and the finished formulation to confirm consistency between declared composition and biological performance.

Testing Items

The specific test parameters depend on product type and registration requirements, and typically include the following:

• Complete protection time (CPT) against landing and probing mosquitoes
• Protection rate comparing treated versus untreated control exposure
• Knockdown rate (KT50 and KT90) for vaporizing and spatial products
• 24-hour mortality for products with insecticidal action
• Species-specific efficacy against Aedes albopictus, Aedes aegypti, Culex pipiens pallens, and Anopheles species
• Duration-of-protection verification supporting label claims
• Field efficacy under natural mosquito population conditions

Testing Methods

Arm-in-Cage Laboratory Test

The standard laboratory procedure for skin repellents follows the arm-in-cage design specified in GB/T 13917.9 and equivalent WHO test protocols. Laboratory-reared, non-blood-fed female mosquitoes, typically 3 to 7 days post-emergence and maintained under controlled conditions of approximately 26 ± 2 °C and 60 ± 10 % relative humidity, are held in mesh test cages at a defined population density.

A measured dose of the test product is applied to a marked area on the forearm of each volunteer, following the labeled application rate. Prior to treatment, the untreated arm serves as a negative control to confirm mosquito avidity. At fixed observation intervals, the treated arm is inserted into the cage for a standard exposure period, usually several minutes, and any landing, probing, or biting event is recorded. The test continues until the defined failure criterion is reached—commonly the first confirmed landing or bite—establishing the complete protection time for that volunteer.

Results are reported as the median or mean CPT across all volunteers, with the number of volunteers, mosquito species, dose, and environmental conditions documented. Studies involving human subjects require informed consent, volunteer health screening, ethical review, and exclusion of insecticide-resistant or pathogen-infected mosquito strains.

Chamber and Room Tests for Vaporizing Products

Spatial repellent formulations are evaluated in standardized test chambers or glass chambers of specified volume. Mosquitoes are released into the chamber, the device or formulation is operated according to labeled instructions, and knockdown and mortality are recorded at predetermined intervals. Protection rate is calculated by comparing landing counts in treated chambers versus untreated controls.

Field Efficacy Trials

Field trials are conducted in natural mosquito habitats—such as parks, wetlands, or residential perimeters—during peak mosquito activity periods. Treated and untreated volunteers perform simultaneous standardized exposure activities, and landing or biting counts are recorded at regular intervals. The field protection rate is calculated as the percentage reduction in landings on treated subjects relative to controls. These trials substantiate laboratory findings and support real-world label claims.

Evaluation Criteria

Under the GB/T 13917.9 evaluation framework, skin repellents are graded based on complete protection time, with Grade A typically corresponding to six hours or more of protection and Grade B corresponding to at least four hours. Products generally must achieve the minimum qualifying grade—commonly Grade B or above—to be eligible for registration, though exact thresholds depend on the current regulatory requirements and the intended label claim. Vaporizing products must meet defined thresholds for knockdown rate, mortality, and protection rate at the labeled dosage.

Applications

Mosquito repellent efficacy testing supports a wide range of regulatory and commercial objectives:

• Registration dossiers submitted to national pesticide registration authorities for new repellent products and renewals
• Substantiation of duration-of-protection and efficacy claims on product labels and advertising materials
• Formulation development, active ingredient screening, and competitive benchmarking during research and development
• Quality control and batch consistency verification for commercial production
• Compliance support for export registrations under WHO guidelines and other regional regulatory schemes
• Response to market surveillance inquiries and post-registration efficacy verification

FAQ

What is complete protection time (CPT)?

Complete protection time is the interval between application of a repellent to human skin and the first confirmed mosquito landing or probing event during standardized testing. It is the principal metric used by regulators to evaluate and grade skin repellent performance.

Which mosquito species are used in the tests?

Laboratory tests commonly use female Aedes albopictus or Aedes aegypti, which are aggressive daytime biters, while Culex pipiens pallens and Anopheles species may be added depending on the target use scenario and registration requirements. All test insects are laboratory-reared, susceptible strains of a defined age.

Are human volunteers required, and how is safety ensured?

Yes, skin repellent testing requires human volunteers because repellent efficacy cannot be fully modeled in vitro. Studies follow strict ethical requirements, including informed consent, health screening of participants, use of pathogen-free laboratory mosquitoes, close medical monitoring, and immediate withdrawal procedures if skin irritation occurs.

How long does a repellent efficacy study take?

A standard laboratory CPT study is typically completed within a few weeks, including mosquito colony preparation and volunteer scheduling. Field trials depend on seasonal mosquito activity and may require several additional weeks. The complete registration dossier review timeline is determined by the regulatory authority.

Is field testing mandatory for registration?

Requirements vary by jurisdiction and product type. Laboratory efficacy data per GB/T 13917.9 is the core requirement for skin repellents in most national schemes, while field data is frequently requested to support extended duration claims or spatial repellent registrations.

Can plant-based or natural repellents be tested under the same protocol?

Yes. Essential-oil-based and other natural repellents are evaluated using the same arm-in-cage methodology and CPT endpoint as synthetic repellents, ensuring that all products on the market meet uniform efficacy standards regardless of active ingredient origin.